Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2002-02-22
2010-11-02
Azpuru, Carlos A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
Reexamination Certificate
active
07824700
ABSTRACT:
A composition for administration of a beneficial agent, contains a solvent mixture including a hydrophobic solvent and a hydrophilic solvent; a bioerodible polymer; and a beneficial agent. The polymer and the beneficial agent are dissolved. The composition has a low viscosity, allowing for easy injection through standard hypodermic needles.
REFERENCES:
patent: 4297344 (1981-10-01), Schwinn et al.
patent: 4938763 (1990-07-01), Dunn et al.
patent: 4975271 (1990-12-01), Dunn et al.
patent: 5019400 (1991-05-01), Gombotz et al.
patent: 5077049 (1991-12-01), Dunn et al.
patent: 5096885 (1992-03-01), Pearlman et al.
patent: 5133981 (1992-07-01), Harkrader et al.
patent: 5242910 (1993-09-01), Damanj
patent: 5278201 (1994-01-01), Dunn et al.
patent: 5278202 (1994-01-01), Dunn et al.
patent: 5324519 (1994-06-01), Dunn et al.
patent: 5324520 (1994-06-01), Dunn et al.
patent: 5340849 (1994-08-01), Dunn et al.
patent: 5368859 (1994-11-01), Dunn et al.
patent: 5487897 (1996-01-01), Polson et al.
patent: 5556905 (1996-09-01), Frappier et al.
patent: 5589167 (1996-12-01), Cleland et al.
patent: 5591713 (1997-01-01), Igari et al.
patent: 5599552 (1997-02-01), Dunn et al.
patent: 5651986 (1997-07-01), Brem et al.
patent: 5665394 (1997-09-01), Igari et al.
patent: 5747058 (1998-05-01), Tipton et al.
patent: 5780044 (1998-07-01), Yewey et al.
patent: 5783205 (1998-07-01), Berggren et al.
patent: 5912015 (1999-06-01), Bernstein et al.
patent: 5945115 (1999-08-01), Dunn et al.
patent: 5972370 (1999-10-01), Eckenhoff et al.
patent: 5980945 (1999-11-01), Ruiz
patent: 6007845 (1999-12-01), Domb et al.
patent: 6039977 (2000-03-01), Venkatraman et al.
patent: 6051259 (2000-04-01), Johnson et al.
patent: 6066619 (2000-05-01), Stevenson et al.
patent: 6080429 (2000-06-01), Cleland et al.
patent: 6087324 (2000-07-01), Igari et al.
patent: 6110503 (2000-08-01), Rickey et al.
patent: 6113943 (2000-09-01), Okada et al.
patent: 6113947 (2000-09-01), Cleland et al.
patent: 6120789 (2000-09-01), Dunn
patent: 6124261 (2000-09-01), Stevenson et al.
patent: 6130200 (2000-10-01), Brodbeck et al.
patent: 6143314 (2000-11-01), Chandrashekar et al.
patent: 6146662 (2000-11-01), Jao et al.
patent: 6165508 (2000-12-01), Tracy et al.
patent: 6174547 (2001-01-01), Dong et al.
patent: 6190700 (2001-02-01), Okada et al.
patent: 6191107 (2001-02-01), Yamagata et al.
patent: 6197350 (2001-03-01), Yamagata et al.
patent: 6331311 (2001-12-01), Brodbeck et al.
patent: 6372245 (2002-04-01), Bowman et al.
patent: 6468961 (2002-10-01), Brodbeck et al.
patent: 2002/0034532 (2002-03-01), Brodbeck et al.
patent: 2003/0044467 (2003-03-01), Brodbeck et al.
patent: 2324265 (1999-09-01), None
patent: 0 216 485 (1987-04-01), None
patent: 0 484 387 (1994-01-01), None
patent: 0 467 389 (1999-10-01), None
patent: 0 949 905 (2001-07-01), None
patent: 8-505139 (1996-06-01), None
patent: 2004-511431 (2004-04-01), None
patent: 173182 (1994-07-01), None
patent: WO 89/03671 (1989-05-01), None
patent: WO 92/17200 (1992-10-01), None
patent: WO 97/26015 (1997-07-01), None
patent: WO 98/27962 (1998-07-01), None
patent: WO 98/27962 (1998-07-01), None
patent: WO 98/27963 (1998-07-01), None
patent: WO 99/47073 (1999-09-01), None
patent: WO 00/78335 (2000-12-01), None
patent: WO-02/00137 (2002-01-01), None
patent: WO 03/041684 (2003-05-01), None
patent: WO 03/041757 (2003-05-01), None
Hawley's Medical Dictionary, “Emulsion”, 14th Edition, 2002.
Lfe Science Dictionary, “Emulsion”, 1995-1998.
Arakawa et al., “Protein-Solvent Interactions in Pharmaceutical Formulations”,Pharmaceutical Research, vol. 8, No. 3 (1991) 285-291.
Gray et al., “Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein”,Proc. Natl. Acad. Sci.USA, vol. 87 (1990) 7380-7384.
Johnson et al., “A month-long effect from a single injection of microencapsulated human growth hormone”,Nature Medicine, vol. 2, No. 7 (1996) 795-799.
Kita et al., “Contribution of the Surface Free Energy Perturbation to Protein-Solvent Interactions”,Biochemistry, vol. 33 (1994) 15178-15189.
Kohno et al., “A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor”,Proc. Natl. Acad. Sci.USA, vol. 87 (1990) 8331-8335.
Lai et al., “Metal and RNA Binding Properties of the hdm2 Ring Finger Domain”,Biochemistry, vol. 37, No. 48 (1998) 17005-17015.
Lin et al., “On the role of surface tension in the stabilization of globular proteins”,Protein Science, vol. 5 (1996) 372-381.
Maa et al., “Spray-Drying of Air-Liquid Interface Sensitive Recombinant Human Growth Hormone”,Journal of Pharmaceutical Sciences, vol. 87, No. 2 (1998) 152-159.
Sackett et al., “Multivalent Cations Depress Ligand Binding to Cell-Associated Insulin-Like Growth Factor Binding Protein-5 on Human Glioblastoma Cells”,Endocrinology, vol. 139, No. 4 (1998) 1943-1951.
Smith et al., “A Novel Parenteral Delivery System”,Pharmaceutical Research, PDD 7270, vol. 13, No. 3 (1996) 1 page.
Timasheff, S.N., “The Control of Protein Stability and Association by Weak Interactions with Water: How Do Solvents Affect These Processes?”Annu. Rev. Biophys. Biomol. Struct., vol. 22 (1993) 67-97.
Timasheff, S.N., “Control of Protein Stability and Reactions by Weakly Interacting Cosolvents: The Simplicity of the Complicated”,Advances in Protein Chemistry, vol. 51 (1998) 355-432.
Timasheff, S.N., “Solvent Stabilization of Protein Structure”,Methods in Molecular Biology, vol. 40 (1995) 253-269.
Xie et al., “The thermodynamic mechanism of protein stabilization by trehalose”,Biophysical Chemistry, vol. 64 (1997) 25-43.
Yang et al., “Effect of Zinc Binding and Precipitation on Structures of Recombinant Human Growth Hormone and Nerve Growth Factor”,Journal of Pharmaceutical Sciences, vol. 89, No. 11 (2000) 1480-1485.
Israeli Office Action for Application No. 157531, dated Jul. 25, 2007, 2 pages (English Translation only).
Cleland Jeffrey L.
Okumu Franklin
Azpuru Carlos A
Genentech Inc.
Morrison & Foerster / LLP
LandOfFree
Erodible polymers for injection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Erodible polymers for injection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erodible polymers for injection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4169860